Top 20 global biopharma firms see 1.7 per cent market cap growth to $3.7 billion in 2024 amid policy…
The industry’s outlook remains uncertain as it navigates complex economic and political dynamics, reveals GlobalData
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.